• Burmese
Thursday, July 17, 2025
No Result
View All Result
NEWSLETTER
The Irrawaddy
26 °c
Yangon
  • Home
  • News
    • Burma
    • Politics
    • World
    • Asia
    • Myanmar’s Crisis & the World
    • Ethnic Issues
    • War Against the Junta
    • Junta Cronies
    • Conflicts In Numbers
    • Junta Watch
    • Fact Check
    • Investigation
    • Myanmar-China Watch
    • Obituaries
  • Politics
  • Business
  • Opinion
    • Commentary
    • Guest Column
    • Analysis
    • Editorial
    • Stories That Shaped Us
    • Letters
  • Junta Watch
  • Ethnic Issues
  • War Against the Junta
  • In Person
    • Interview
    • Profile
  • Books
  • Donation
  • Home
  • News
    • Burma
    • Politics
    • World
    • Asia
    • Myanmar’s Crisis & the World
    • Ethnic Issues
    • War Against the Junta
    • Junta Cronies
    • Conflicts In Numbers
    • Junta Watch
    • Fact Check
    • Investigation
    • Myanmar-China Watch
    • Obituaries
  • Politics
  • Business
  • Opinion
    • Commentary
    • Guest Column
    • Analysis
    • Editorial
    • Stories That Shaped Us
    • Letters
  • Junta Watch
  • Ethnic Issues
  • War Against the Junta
  • In Person
    • Interview
    • Profile
  • Books
  • Donation
No Result
View All Result
The Irrawaddy
No Result
View All Result
Home News World

Health Groups Ask India to Rescind Gilead’s Patents for COVID-19 Drug

Reuters by Reuters
May 15, 2020
in World
Reading Time: 2 mins read
0 0
A A
Gilead Sciences Inc. pharmaceutical company’s headquarters in Oceanside, California / REUTERS

Gilead Sciences Inc. pharmaceutical company’s headquarters in Oceanside, California / REUTERS

3.7k
VIEWS
Share on FacebookShare on Twitter

NEW DELHI—Two health advocacy groups have written to the Indian government asking it to rescind patents given to Gilead Sciences for the drug remdesivir so it can be distributed more fairly to coronavirus patients around the world, particularly in poorer nations.

Drug patents in India are an important issue as many countries depend on generic drugmakers to make and sell cheaper versions of critical drugs to them. Gilead’s three patents in India for remdesivir stem from 2009 when the drug was in development to treat Ebola.

Remdesivir is the only drug approved to treat COVID-19 patients after promising early trial results prompted U.S. regulators to grant emergency use authorization on May 2.

RelatedPosts

Indian Army Accused of Deadly Strike on Separatists in Myanmar

Indian Army Accused of Deadly Strike on Separatists in Myanmar

July 15, 2025
2.2k
Mekong River Body Detects Heavy Metal Contamination

Mekong River Body Detects Heavy Metal Contamination

July 7, 2025
670
Toxic Thailand Rivers Pinned on Myanmar Mines

Toxic Thailand Rivers Pinned on Myanmar Mines

June 11, 2025
790

To expand its access, Gilead said this week it had signed non-exclusive licensing pacts with five generic drugmakers based in India and Pakistan, allowing them to make and sell remdesivir for 127 countries.

But health access groups say the pacts mean cheaper forms of the drug may not become available in nations seen as non-profitable to the five drugmakers.

“The licenses divide the global market into two and profitable markets are retained with Gilead and less profitable markets are given to the five generic companies,” said K. Gopakumar, senior legal researcher at Third World Network, which sent a letter to the Indian government on Wednesday.

The letter by Third World Network, a Malaysia-based non-profit group, followed a similar appeal by India’s Cancer Patients Aid Association last week.

The aid group Doctors Without Borders has also opposed Gilead’s patents on remdesivir, saying such licensing pacts are “not acceptable” amid a global health emergency.

Gilead’s patents on remdesivir in India allow it to exclusively make and sell the drug in the country until 2035 unless it licenses those rights out.

A Gilead spokeswoman told Reuters in an email that the company is “actively considering every potential pathway” to make the drug available to those who need it as fast as possible.

She said the company was in talks with the UN-backed Medicines Patent Pool and the United Nations Children’s Fund to expand access to it.

“Compulsory licensing will not solve the challenge of limited supply,” the spokeswoman said, referring to a provision under which countries can allow manufacturers to make certain drugs without the patent owner’s consent.

India’s commerce and health ministries did not immediately respond to emails seeking comment.

India’s Cancer Patients Aid Association said it might pursue legal action, noting that cancer patients have compromised immunity and are highly susceptible to the virus.

“It is imperative at a time like this that no monopoly rights be granted, so that more manufacturers can produce the drug to be made available to all the people who need it, at affordable costs,” it said.

Except for remdesivir, there are currently no other drugs or vaccines approved to fight coronavirus, which has killed more than 200,000 people globally.

You may also like these stories:

New Zealand Lifts State of Emergency as COVID-19 Cases Decrease

US Accuses China-Linked Hackers of Stealing Coronavirus Research

Your Thoughts …
Tags: COVID-19EqualityHealthIndiaMedicine
Reuters

Reuters

...

Similar Picks:

Myanmar’s Blackout Junta Seeks Solar Power Aid From Neighbors
Burma

Myanmar’s Blackout Junta Seeks Solar Power Aid From Neighbors

by The Irrawaddy
February 14, 2025
14.9k

China and India have been approached for help with solar power projects, the electricity minister says, as the country’s chronic...

Read moreDetails
China and the Wars in Myanmar
Guest Column

China and the Wars in Myanmar

by Bertil Lintner
January 21, 2025
10.7k

Recent truces declared by ethnic armies show that China is still the only outside power that can intervene in Myanmar,...

Read moreDetails
Myanmar Junta Rejects Bangladeshi Call for Rohingya State
Burma

Myanmar Junta Rejects Bangladeshi Call for Rohingya State

by Maung Kavi
May 2, 2025
10.4k

A political party in Bangladesh says a Rohingya-majority area of Rakhine State should become an independent state for returning refugees.

Read moreDetails
China’s Export Ban is Causing Shortages of Medicine, Fuel And Food in Myanmar
Business

China’s Export Ban is Causing Shortages of Medicine, Fuel And Food in Myanmar

by The Irrawaddy
October 28, 2024
10k

Beijing’s crackdown on border trade with Myanmar is aggravating the post-coup economic crisis and the construction sector could see a...

Read moreDetails
Myanmar’s Youth Flee—and They Aren’t Looking Back
Commentary

Myanmar’s Youth Flee—and They Aren’t Looking Back

by Aung Zaw
February 23, 2024
8.4k

In Thailand and farther afield, they join the wealthy and the educated who have already put down roots and invested...

Read moreDetails
AA Chief: Neighbors Propping Up Myanmar Junta
Politics

AA Chief: Neighbors Propping Up Myanmar Junta

by The Irrawaddy
April 11, 2024
6.4k

Arakan Army leader Major General Tun Myat Naing says neighboring countries are allowing the regime to remain in power.

Read moreDetails
Load More
Next Post
A medical worker in a protective suit conducts a nucleic acid test on a resident of a housing compound in Wuhan, the Chinese city hit hardest by COVID-19, on May 15, 2020. / REUTERS

China's Wuhan Says It Has Tested Almost a Third of Its Residents for Coronavirus

A pedestrian in Botahtaung Township, downtown Yangon, seen on April 29. Botahtaung is among the four townships in Yangon where some restrictions were lifted on Friday. / Aung Kyaw Htet / The Irrawaddy

Myanmar Extends Ban on Gatherings, Int’l Flights, Other COVID-19 Measures

No Result
View All Result

Recommended

‘Not a Witch Hunt’: Upholding Survivor-Centered Justice in Myanmar

‘Not a Witch Hunt’: Upholding Survivor-Centered Justice in Myanmar

6 days ago
716
‘Reforms Are Not Optional’: Prominent Activist Urges NUG to Act Before It’s Too Late

‘Reforms Are Not Optional’: Prominent Activist Urges NUG to Act Before It’s Too Late

1 week ago
1.4k

Most Read

  • Indian Army Accused of Deadly Strike on Separatists in Myanmar

    Indian Army Accused of Deadly Strike on Separatists in Myanmar

    shares
    Share 0 Tweet 0
  • Rakhine Fighters Close In on Myanmar Junta’s Naval Base

    shares
    Share 0 Tweet 0
  • What the ‘Snake Charmer’ Analogy Gets Wrong About Myanmar

    shares
    Share 0 Tweet 0
  • Myanmar and Russian Regimes Push Indian Trade Corridor to Bypass Western Sanctions

    shares
    Share 0 Tweet 0
  • Myanmar Junta Launches Space Agency With Russian Help

    shares
    Share 0 Tweet 0

Newsletter

Get The Irrawaddy’s latest news, analyses and opinion pieces on Myanmar in your inbox.

Subscribe here for daily updates.

Contents

  • News
  • Politics
  • War Against the Junta
  • Myanmar’s Crisis & the World
  • Conflicts In Numbers
  • Junta Crony
  • Ethnic Issues
  • Asia
  • World
  • Business
  • Economy
  • Election 2020
  • Elections in History
  • Cartoons
  • Features
  • Opinion
  • Editorial
  • Commentary
  • Guest Column
  • Analysis
  • Letters
  • In Person
  • Interview
  • Profile
  • Dateline
  • Specials
  • Myanmar Diary
  • Women & Gender
  • Places in History
  • On This Day
  • From the Archive
  • Myanmar & COVID-19
  • Intelligence
  • Myanmar-China Watch
  • Lifestyle
  • Travel
  • Food
  • Fashion & Design
  • Videos
  • Photos
  • Photo Essay
  • Donation

About The Irrawaddy

Founded in 1993 by a group of Myanmar journalists living in exile in Thailand, The Irrawaddy is a leading source of reliable news, information, and analysis on Burma/Myanmar and the Southeast Asian region. From its inception, The Irrawaddy has been an independent news media group, unaffiliated with any political party, organization or government. We believe that media must be free and independent and we strive to preserve press freedom.

  • Copyright
  • Code of Ethics
  • Privacy Policy
  • Team
  • About Us
  • Careers
  • Contact
  • Burmese

© 2023 Irrawaddy Publishing Group. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Burma
    • Politics
    • World
    • Asia
    • Myanmar’s Crisis & the World
    • Ethnic Issues
    • War Against the Junta
    • Junta Cronies
    • Conflicts In Numbers
    • Junta Watch
    • Fact Check
    • Investigation
    • Myanmar-China Watch
    • Obituaries
  • Politics
  • Opinion
    • Commentary
    • Guest Column
    • Analysis
    • Editorial
    • Stories That Shaped Us
    • Letters
  • Ethnic Issues
  • War Against the Junta
  • In Person
    • Interview
    • Profile
  • Business
    • Economy
    • Business Roundup
  • Books
  • Donation

© 2023 Irrawaddy Publishing Group. All Rights Reserved

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.